Walmart-owned Flipkart is reportedly in talks to acquire a stake in Bengaluru-based healthtech start-up Pharmallama, in accordance to a report by Livemint. People aware of the matter instructed Mint that Flipkart could even acquihire this start-up moreover gaining entry to the applied sciences of this platform.
Pharmallama, which is run by Mera Dawai Pvt. Ltd., was began in 2020 by Achintya Dayal, Arjun Raghunandan and Deepesh Rajpal. The online pharmacy start-up competes with manufacturers like Netmeds, Tata1mg, Pharmeasy, Apollo, and others in the market. Pharmeasy, which was supposed to go public this 12 months, shelved its plans citing prevailing market circumstances as the rationale.
Flipkart forayed into the healthcare phase in 2021 when it acquired a majority stake in SastaSundar Marketplace Ltd. The Kolkata-based firm operates online pharmacy and digital healthcare platform, SastaSundar.com. The ecommerce big additionally has invested in the healtech platform, BeatO by its enterprise capital arm, Flipkart Ventures.
Recently, tech majors together with Amazon and Flipkart Health Plus got here underneath the scanner after the Drugs Controller General of India (DCGI) despatched them and 20 different online retailers for the unlawful sale of medicine online.
“In spite of the identical, you’re discovered to be engaged in such actions with out a licence,” says the warning to the online pharmaceutical distributors who’re breaking the principles.
“…You are hereby requested to present trigger inside 2 days from the date of challenge of this discover, why motion shall not be taken towards you on the market, or inventory, or exhibit or provide on the market or distribution of medicine in contravention of the provisions of the Drugs and Cosmetics Act 1940 and guidelines made thereunder,” the discover learn.
The notification, dated February 8, by DCGI’s VG Somani, cited a Delhi High Court judgement dated December 12, 2018. The notification prohibits the sale of medicine online with out a licence.
The DCGI stated that if there isn’t any response, it is going to be assumed that the corporate will not touch upon the subject and essential motion might be taken towards them with out additional discover.
Also learn: RIL vs TCS: Should you purchase Reliance Industries or Tata Consultancy Services shares after a uninteresting 12 months?
Also learn: LIC simply elevated stake in these 10 firms; must you purchase?
